BIOL 375 Virology: Difference between revisions
Slonczewski (talk | contribs) |
Slonczewski (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
[[Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients]] by Sally Wilson</b> | [[Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients]] by Sally Wilson</b> | ||
[[Mimivirus]] by Andrew Cheever | |||
Revision as of 15:57, 3 December 2010
BIOL 375 Virology: Term Projects 2010
Human Chromosomal Integration of Latent State Human Herpes Virus 6 (HHV-6) by Kerri-Lynn Conrad
Infection Mechanism of Genus Ebolavirus by Keith Miller
Dengue transmission by Kelly Wahl
Telaprevir (VX-950) a novel antiviral treatment for Hepatitis C virus patients by Sally Wilson
Mimivirus by Andrew Cheever
Short pages in 2010 by the class BIOL 375 Virology:
Bluetongue Virus (BTV) by Kerri-Lynn Conrad
Fibropapilloma-Associated Turtle Herpesvirus by Keith Miller
Venezuelan equine encephalitis virus by Kelly Wahl
Cucurbit yellow stunting disorder virus (CYSDV) by Sally Wilson
Short pages in 2008 by the class BIOL 375 Virology.
Kashmir Bee Virus by Devon Fitzgerald
Mouse Mammary Tumor Virus by Piero Sanfilippo
Rinderpest by Trevor Brolin
Tospovirus by Sasha Minian
